Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.66 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.66 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 9/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | HPGD | P15428 | 5/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.59 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.57 |
| ▸ | ATP4A | P20648 | 1/20 | 0.54 |
| ▸ | ATP4B | P51164 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29518902 | 0.96 | KDM4E (0.61) | KDM4ELMNAHSP90AA1HSP90AB1MEN1 | |
| SCHEMBL17412180 | 0.96 | KDM4E (0.61) | KDM4ELMNAHSP90AA1HSP90AB1MEN1 | |
| SCHEMBL17412405 | 0.96 | KDM4E (0.61) | KDM4ELMNAHSP90AA1HSP90AB1MEN1 | |
| SCHEMBL17412407 | 0.96 | KDM4E (0.61) | KDM4ELMNAHSP90AA1HSP90AB1MEN1 | |
| SCHEMBL6504250 | 0.92 | CTRC (0.58) | KDM4ELMNAHSP90AA1HSP90AB1MEN1 | |
| SCHEMBL38654829 | 0.92 | CTRC (0.58) | KDM4ELMNAHSP90AA1HSP90AB1MEN1 | |
| SCHEMBL22225596 | 0.91 | KDM4E (0.56) | KDM4ELMNAHSP90AA1HSP90AB1MEN1 | |
| SCHEMBL22376054 | 0.90 | KDM4E (0.59) | KDM4ELMNAHSP90AA1HSP90AB1MEN1 | |
| SCHEMBL17412388 | 0.90 | LMNA (0.59) | KDM4ELMNAHSP90AA1HSP90AB1MEN1 | |
| SCHEMBL29450767 | 0.90 | LMNA (0.59) | KDM4ELMNAHSP90AA1HSP90AB1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 825 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060084645-A1 | Novel pyrimidine compounds, process for their preparation and compositions containing them | DR. REDDY'S LABORATORIES LTD. (IN) | 2006-04-20 | — | — | US | claimed |
| WO-2026101205-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 솔루스첨단소재 주식회사 | 2026-05-15 | — | — | WO | disclosed |
| WO-2026101206-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 솔루스첨단소재 주식회사 | 2026-05-15 | — | — | WO | disclosed |
| CN-122029252-A | Organic light-emitting compound and organic electroluminescent device comprising the same | 索路思高新材料有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4600325-B1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | SOLUS ADVANCED MATERIALS CO LTD (KR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4692276-A2 | ORGANIC MOLECULES WITH A TRIFLUOROMETHYL-BIPHENYL CORE FOR USE IN OPTOELECTRONIC DEVICES | Samsung Display Co., Ltd. (KR) | 2026-02-11 | — | — | EP | disclosed |
| EP-3724181-B1 | ORGANIC MOLECULES WITH A TRIFLUOROMETHYL-BIPHENYL CORE FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2026-01-28 | — | — | EP | disclosed |
| US-12532601-B2 | Organic compound and organic electroluminescent device comprising same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2026-01-20 | — | — | US | disclosed |
| EP-4046992-B1 | NITRILE SUBSTITUTED AND SPIRO-CONDENSED FLUORENES AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | SOLUS ADVANCED MATERIALS CO LTD (KR) | 2025-12-17 | — | — | EP | disclosed |
| US-20250361207-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2025-11-27 | — | — | US | disclosed |
| US-20070032510-A1 | Substituted pyrimidines as ligands of adenosine receptors | UNIVERSITEIT LEIDEN (NL) | 2007-02-08 | — | — | US | disclosed |
| EP-1667985-A1 | SUBSTITUTED PYRIMIDINES AS LIGANDS OF ADENOSINE RECEPTORS | Universiteit Leiden (NL) | 2006-06-14 | — | — | EP | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| US-20060084645-A1 | Novel pyrimidine compounds, process for their preparation and compositions containing them | DR. REDDY'S LABORATORIES LTD. (IN) | 2006-04-20 | — | — | US | disclosed |
| WO-2006034473-A2 | NOVEL PYRIMIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | REDDY US THERAPEUTICS, INC. (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| WO-2005033084-A1 | SUBSTITUTED PYRIMIDINES AS LIGANDS OF ADENOSINE RECEPTORS | UNIVERSITEIT LEIDEN (NL) | 2005-04-14 | — | — | WO | disclosed |
| EP-0826673-B1 | ACETAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME | DAINIPPON PHARMACEUTICAL CO (JP) | 2002-11-20 | — | — | EP | disclosed |
| US-5972946-A | NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0826673-A1 | ACETAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1998-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060084645-A1 | Novel pyrimidine compounds, process for their preparation and compositions containing them | UMPS, DPYD, TYMS | KDM4E 3484/4885LMNA 704/4885HSP90AA1 3866/4885 |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | KDM4E 4854/4885LMNA 4152/4885HSP90AA1 2426/4885 |
| US-20070032510-A1 | Substituted pyrimidines as ligands of adenosine receptors | ADORA2A, ADORA3, ADORA1 | KDM4E 4307/4885LMNA 4202/4885HSP90AA1 2749/4885 |
| US-12532601-B2 | Organic compound and organic electroluminescent device comprising same | TRPC6, TRPC1, KCNN1 | KDM4E 3378/4885LMNA 401/4885HSP90AA1 2715/4885 |
| US-20250361207-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NR2E3, ORC3 | KDM4E 2599/4885LMNA 4113/4885HSP90AA1 4815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.